Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Asensus Announces A Senhance Surgical System Has Been Sold To The Company’s Distribution Partner In Germany
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a
Cantor Fitzgerald Initiates Coverage On This ‘Attractively Valued’ MedTech Stock
Cantor Fitzgerald initiated coverage on Asensus Surgical Inc (NYSE:ASXC) with an Overweight rating and a price target of $1.50. ASXC is a…
Asensus Surgical’s Return On Capital Employed Overview
Benzinga Pro data, Asensus Surgical (AMEX:ASXC) reported Q2 sales of $994 thousand. Earnings fell to a loss of $19.62 million, resulting in a 2.57% decrease from last quarter.
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Lowers Price Target to $3
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and lowers the price target from $4 to $3.
Recap: Asensus Surgical Q2 Earnings
Asensus Surgical (AMEX:ASXC) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Asensus Surgical Earlier Announced Sale Of Senhance Robotic System
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a
Asensus Surgical Announces Installation Of Senhance Surgical System In The Department Of Gynecology At University Hospital Tübingen
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the